Katie Streicher

IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE

Shu Wang, Jingya Wang, Varsha Kumar et al. · Nature Communications · 2018 · 569 citations · Full text

Life Sciences, Immunology, Nephrology +17

Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial

Christopher E. Brightling, Pascal Chanez, Richard Leigh et al. · The Lancet Respiratory Medicine · 2015 · 366 citations

Medicine, Clinical Sciences, Immunology +8

Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer

Liyan Jiang, Jiaqi Huang, Brandon W. Higgs et al. · PLoS Genetics · 2016 · 279 citations · Full text

Life Sciences, Genetics, Oncology +16

Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial

Hugh Montgomery, Richard Hobbs, Francisco Padilla et al. · The Lancet Respiratory Medicine · 2022 · 227 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +5

Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab

Brandon W. Higgs, Christopher Morehouse, Katie Streicher et al. · Clinical Cancer Research · 2018 · 220 citations · Full text

Medicine, Molecular Medicine, Oncology +17